Infectious complications associated with immunomodulating biologic agents

Sophia Koo; Francisco M Marty; Lindsey R Baden

doi:10.1016/j.hoc.2010.11.009

Infectious complications associated with immunomodulating biologic agents

Hematol Oncol Clin North Am. 2011 Feb;25(1):117-38. doi: 10.1016/j.hoc.2010.11.009.

Authors

Sophia Koo¹, Francisco M Marty, Lindsey R Baden

Affiliation

¹ Division of Infectious Diseases, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

PMID: 21236394
DOI: 10.1016/j.hoc.2010.11.009

Abstract

The armamentarium of biologic therapies targeting specific elements of the immune system is rapidly expanding. This review describes the spectrum of infectious complications associated to date with each of the immunomodulating biologic therapies approved by the US Food and Drug Administration.